首页> 外文期刊>Small GTPases >The P-Rexl/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses
【24h】

The P-Rexl/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses

机译:P-REXL / RAC信令路径作为她/ erbB受体和GPCR反应的收敛点

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Guanine nucleotide Exchange Factors (GEFs) are responsible for mediating GDP/GTP exchange for specific small G proteins, such as Rac. There has been substantial evidence for the involvement of Rac-GEFs in the control of cancer cell migration and metastatic progression. We have previously established that the Rac-GEF P-Rex1 is a mediator of actin cytoskeleton rearrangements and cell motility in breast cancer cells downstream of HER/ErbB receptors and the G-Protein Coupled Receptor (GPCR) CXCR4. P-Rex1is highly expressed in luminal A and B breast cancer compared to normal mammary tissue, whereas expression is very low in basal breast cancer, and its expression correlates with the appearance of metastasis in patients. Here, we discuss the involvementof P-Rex1 as an effector of oncogenic/metastatic receptors in breast cancer and underscore its relevance in the convergence of receptor-triggered motile signals. In addition, we provide an overview of our recent findings describing a cross-talk between HER/ErbB receptors and CXCR4, and how this impacts on the activation of P-Rex1/Rac1 signaling, as well as highlight challenges that lie ahead. We propose a model in which P-Rexl acts as a crucial node for the integration of upstream inputs from HER/ErbB receptors and CXCR4 in luminal breast cancer cells.
机译:鸟嘌呤核苷酸交换因子(全球环境基金)负责对特定的小G蛋白(例如RAC)介导GDP / GTP交换。 Rac-GEF在癌细胞迁移和转移性进展中涉及rac-gef的涉及有实质性证据。我们之前已经确定RAC-GEF P-REX1是肌动蛋白细胞骨架重排的介质和在她/ erbB受体下游的乳腺癌细胞中的乳腺癌细胞和G蛋白偶联受体(GPCR)CXCR4的细胞运动。与正常乳腺组织相比,P-Rex1在腔A和B乳腺癌中高度表达,而表达在基础乳腺癌中非常低,其表达与患者转移的外观相关。在这里,我们讨论p-Rex1作为乳腺癌中致癌/转移受体的效应的涉及,并且强调其在受体触发动机信号的收敛性中的相关性。此外,我们还概述了我最近的研究结果,描述了她/ erbB受体和CXCR4之间的串扰,以及如何影响对P-REX1 / RAC1信令的激活,以及突出的挑战。我们提出了一种模型,其中P-REXL充当用于在腔乳腺癌细胞中与CXCR4中的上游输入集成的关键节点。

著录项

  • 来源
    《Small GTPases》 |2018年第6期|共7页
  • 作者单位

    Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia PA USA;

    Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia PA USA;

    Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia PA USA;

    Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia PA USA;

    Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia PA USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

    breast cancer; CXCR4 HER/ErbB receptors; P-Rexl; Racl;

    机译:乳腺癌;CXCR4 HER / ERBB受体;P-REXL;RACL;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号